Cancer Immunology
In 2013, Dr. Vijayanand teamed up with Professor Christian Ottensmeier at the Cancer Center, University of Southampton, UK, to
In 2013, Dr. Vijayanand teamed up with Professor Christian Ottensmeier at the Cancer Center, University of Southampton, UK, to
New LJI research could guide the development of more effective cancer immunotherapies
New funding will support high-risk, high-reward projects led by two early-career scientists
Myers Lab to expand autoimmune disease research, cancer and more
LA JOLLA—Scientists at La Jolla Institute for Immunology (LJI) have received a new grant of more than $2.3 million from the National
LA JOLLA—Neutrophils are the warriors of the immune system. They are always ready to spring to action to help heal
Preliminary data from our lab shows that vascular endothelial cells (vECs) mount remarkably potent innate responses to cell-free DNA, which
Cell-free, immuno-stimulatory DNA is recognized in the cytoplasm of cells as a universal danger signal by the innate immune system.
Immunotherapies for head and neck cancer: To develop new cancer therapies by studying how the immune system, by way of
MHC class-II restricted CD4+ T cytotoxic cells (CD4 CTL) are among the best examples of extreme measures the immune system
Recent work by others has provided evidence that, in contrast to conventional T cells, PKCq negatively regulates the suppressive activity